DIA Europe
DIA EUROPE is the largest neutral event in the European life science industry – where science, healthcare and regulation meet to make new connections and advance health priorities. On Thursday, March 23 at 16:50 as part of a session on the digital patient experience, Kelly Dumais will present BYOD as the solution for improved reach and impact of ePROs.
Session Information:
Title: #S0205-H: The Digital Patient Experience: Optimising the Use of Technologies For Patient Use in Clinical Trials
Track: 02 Clinical Trials Development and Operations
Date: Thursday, March 23rd, 2023
Time: 16:50 – 18:00, Delhi (GF)
Title: BYOD: the silver bullet in expanding the reach and impact of patient reported outcomes
Objectives:
- Participants will be able to appraise the appropriateness of BYOD to their own DCT strategy
- Participants will be able to identify the potential benefits of integrating a BYOD strategy should be integrated in to their DCT protocols
Overview:
BYOD should bring a more patient centric focus to DCTs but progress has been slow. Kelly’s presentation will explore why this has been the case in the past, why we should persevere with BYOD and how and when to accelerate its adoption.
Details:
Patients’ ability to submit Patient Reported Outcomes (ePRO) using their own smartphones (BYOD) has the potential to reduce burden and has expanded the reach of hybrid and decentralized trials. While there is consensus on device equivalency, impact on patient compliance is not well understood and there remains the important question “are we technically, operationally, and scientifically ready for a device agnostic approach to COA data collection?” Although the concept of BYOD is not new, having been a topic of debate and discussion in the industry for over a decade, progress in establishing clear recommendations for when, why, and how to implement BYOD solutions, particularly for primary or secondary endpoint data collection in pivotal clinical trials, is lacking. In this presentation, we will examine the promise of BYOD of creating more patient-centric clinical trials and provide a roadmap for where we need to go to successfully execute BYOD solutions.
Speaker
Kelly Dumais, Ph.D.
Principal Scientific Advisor at Clario
Dr. Dumais is a scientist with over 13 years of experience in behavioral and life science research. She has expertise in the implementation of electronic clinical outcome assessments (eCOA) and the development and validation of patient reported outcomes (PROs) to support labeling claims. She is currently a Principal Scientific Advisor at Clario, a global data and technology company that helps to minimize risk in clinical trials. She consults on best practices for questionnaire design and eCOA design/use to drive data integrity and patient engagement and develops custom site rater training and participant training for improving accuracy in COA reporting and improving inter-and intra-rater reliability.